Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Australia to push ahead with reopening amid record COVID-19 cases

Published 03/01/2022, 03:32
Updated 03/01/2022, 03:35
© Reuters. FILE PHOTO: A person wearing a face mask walks along the harbour waterfront across from the Sydney Opera House during a lockdown to curb the spread of coronavirus disease (COVID-19) in Sydney, Australia, October 6, 2021. REUTERS/Loren Elliott

SYDNEY (Reuters) - Australia's government said the milder impact of the Omicron strain of COVID-19 meant the country could push ahead with plans to reopen the economy even as new infections hit a record of more than 37,000 and the number of people hospitalised rose.

Record daily case numbers were reported on Monday in the states of Victoria, Queensland, South Australia and Tasmania, as well as the Australian Capital Territory.

In New South Wales, there were 20,794 cases, higher than Sunday's figure but below the daily record of 22,577 set on Saturday, with testing numbers lower over the New Year's holiday weekend.

The national daily total hit a record of more than 37,150 cases, exceeding Saturday's 35,327 cases, with Western Australia and the Northern Territory still to report.

"We have to stop thinking about case numbers and think about serious illness, living with the virus, managing our own health and ensuring that we're monitoring those symptoms and we keep our economy going," Prime Minister Scott Morrison told Channel Seven.

Hospitalisations rose to 1,204 in New South Wales, up more than 10% from Sunday and more than three times the level on Christmas Day.

Federal Health Minister Greg Hunt said the advice to the government was that the Omicron strain was more transmissible but also milder than other variants, which reduced the risk to both individuals and the health system.

Michael Bonning, chairman of the Australian Medical Association's New South Wales Council, said the significant increase in hospitalisations combined with the peak holiday period and the number of health workers exposed to COVID were putting pressure on capacity.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"With both the Christmas period and with hospital workers being furloughed due to their close contact status.... we're finding that it is becoming quite difficult to staff, especially critical areas of hospitals," he told ABC Television.

In late December, the government changed its advice on when people should get a free PCR test for COIVD-19, and is calling for greater use of rapid antigen tests, in part to relieve pressure on testing capacity.

But the rapid antigen tests are in short supply, and Morrison said the government would not cover the cost for people to test themselves, which he put at A$15 ($10.90).

"We're at another stage of this pandemic now, where we just can't go round and make everything free," he said.

Eight deaths from COVID had been reported on Monday, taking the national toll through the pandemic to more than 2,260.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.